| Anti-CRISPR ID: | anti_CRISPR1316 |
| Accession: | WP_023347629.1 |
| Anti-CRISPR type: | II-A |
| Family: | AcrIIA11 |
| Organism: | |
| Taxonomy: | Bacteria; Firmicutes |
| Uniprot entry: | V2YF85 |
| Uniprot entry name: | V2YF85_9FIRM |
| Structure: | -- |
| Inhibition stage: | |
| Complexed with: | |
| Interactor (DIP): | -- |
| Interactor (STRING): | 1378168.N510_01926; |
| Protein sequence: | MPDELSVRQWQEQFRAGAFNLQDRYTQCRAGWYDWFCQDHALAGRLKKIGRVVMGITDPFILDNYYVWFKNNCPLNGPLYDDARFEPLSGNRDGKYFVISLDSPHERMKWALVTERYGFDAPEFDCRDIREMIRYVNSIGPELQKGVIPPFIAEKDAVTAYARQRGEPEGLHIYRDGDHQYSYTSRRDRRKRTVLAAASLENAPAGFVSEQAHAVKGMYLYCPEDVGIPLPEHPENIKKSREKKGVER |
| Length of sequence: | 248 |
| Verified: | literature |
| Comments: | -- |
| Pubmed: | PMID:31502535 Forsberg KJ, Bhatt IV, Schmidtke DT, et al. Functional metagenomics-guided discovery of potent Cas9 inhibitors in the human microbiome. Elife. 2019;8:e46540. Published 2019 Sep 10. doi:10.7554/eLife.46540 |
| Locus tag: | -- |
| Coding region: | -- |
| Gene name: | N510_01926 |
| Gene ID: | -- |
| Gene Sequence: | -- |
| IDs | Q.start | Q.end | S.start | S.end | Identity | E-value |
| anti_CRISPR1293 | 1 | 248 | 1 | 249 | 84.337 | 2.63e-164 |
| anti_CRISPR1291 | 5 | 248 | 1 | 242 | 55.328 | 5.34e-105 |
| anti_CRISPR1289 | 4 | 248 | 3 | 244 | 55.102 | 4.63e-103 |
| anti_CRISPR1290 | 3 | 221 | 2 | 220 | 60.731 | 5.89e-103 |
| anti_CRISPR1292 | 1 | 248 | 1 | 249 | 48.400 | 3.92e-89 |
| anti_CRISPR1294 | 4 | 150 | 3 | 149 | 67.347 | 4.29e-79 |
| anti_CRISPR1322 | 4 | 144 | 3 | 143 | 47.887 | 1.15e-44 |
| anti_CRISPR1286 | 4 | 144 | 3 | 143 | 46.479 | 2.28e-43 |
| anti_CRISPR1287 | 1 | 137 | 1 | 137 | 42.857 | 2.54e-38 |
| anti_CRISPR1288 | 1 | 137 | 2 | 138 | 34.532 | 2.49e-31 |